<qa>  What is the name of the cytotoxic chemotherapy that patients may continue until they consent to study5. Patients at least 3 weeks from last cytotoxic chemotherapy. Patients may continue tyrosine kinase inhibitors andor lenalidomide until the day of study consent. 